NanoCellect Biomedical

About:

NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.

Top Investors: Warburg Pincus, Agilent Technologies, Anzu Partners, Illumina Ventures, Casdin Capital

Description:

NanoCellect Biomedical develops and delivers microfluidic-based solutions that are affordable, compact, and easy to use. Its expanding portfolio of instruments and consumables enables biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, antibody discovery, and basic research.

Total Funding Amount:

$47M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)nanocellect.com

Founders:

Jose Morachis, Nate Heintzman, Sung Cho, Will Alaynick, Yuhwa Lo

Number of Employees:

51-100

Last Funding Date:

2021-08-13

IPO Status:

Private

Industries: